Back
Ares Management Vs. Avidity Biosciences Industry Stock Comparison
Buy
83
ARES
Ares Management
Last Price:
156.51
Seasonality Move:
-1.63%
Sell
31
RNA
Avidity Biosciences
Last Price:
45.67
Seasonality Move:
-1.3%
Buy
83
Ares Management (ARES)
is a Buy
Is Ares Management a Buy, Sell or Hold?
- The current Ares Management [ARES] share price is $156.51. The Score for ARES is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- ARES is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
31
Avidity Biosciences (RNA)
is a Sell
Is Avidity Biosciences a Buy, Sell or Hold?
- The current Avidity Biosciences [RNA] share price is $45.68. The Score for RNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- RNA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ARES Stock Price Chart
What is Ares Management's stock price today?
-
The Ares Management share price today is $156.51
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARES is experiencing slight buying pressure.
RNA Stock Price Chart
What is Avidity Biosciences's stock price today?
-
The Avidity Biosciences share price today is $45.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNA is experiencing slight buying pressure.
ARES Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.33 | Buy |
Relative Strength Index (14 RSI): | 70.19 | Buy |
Chaikin Money Flow: | 390938 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (140.94 - 149.4) | Buy |
Bollinger Bands (100): | (135.72 - 147.04) | Buy |
RNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 62 | Buy |
Chaikin Money Flow: | 402350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.19 - 44.69) | Buy |
Bollinger Bands (100): | (30.3 - 45.36) | Buy |
ARES Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 147.98 | Buy |
20-day SMA: | 145.24 | Buy |
50-day SMA: | 144.63 | Buy |
200-day SMA: | 133.77 | Buy |
8-day EMA: | 149.63 | Buy |
20-day EMA: | 146.29 | Buy |
50-day EMA: | 143.88 | Buy |
200-day EMA: | 132.66 | Buy |
RNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 42.33 | Buy |
20-day SMA: | 42.39 | Buy |
50-day SMA: | 43.82 | Buy |
200-day SMA: | 26.96 | Buy |
8-day EMA: | 43.04 | Buy |
20-day EMA: | 42.7 | Buy |
50-day EMA: | 41.84 | Buy |
200-day EMA: | 30.49 | Buy |
Ares Management Earnings Growth & ARES Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.35 per share, an increase this year of $0.60 per share, and an increase next year of $1.63 per share.
Avidity Biosciences Earnings Growth & RNA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.20 per share, and a decrease next year of $0.17 per share.
Ares Management Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Avidity Biosciences Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |